Peritumoral Dilation Radiomics of Gd-EOB-DTPA MRI Predicts Early Relapse in Hepatocellular Carcinoma Without Macrovascular Invasion
Huan-Huan Chong1,2, Yu-Da Gong3, Lei Chen4, Xian-Pan Pan4, Ai-E Liu4, Chun Yang2, and Meng-Su Zeng1,2,5
1Shanghai Institute of Medical Imaging, Shanghai, China, 2Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China, 3Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China, 4Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China, 5Department of Medical Imaging, Shanghai Medical College, Fudan University, Shanghai, China
The peritumoral dilation radiomics of Gd-EOB-DTPA MRI is an excellently preoperative biomarker for stratifying the HCC patients at high risk of early recrudescence after hepatectomy.
Flowchart of study population.
Table 1. The discrimination of single sequences in predicting 2-year recurrence with logistic regression.